Dr. Lenka Fedorkova CEO of bioPrime, LLC
Dr. Lenka Fedorkova is a consultant dedicated to facilitating and promoting commercialization of early‐stage biomedical innovations. Dr. Fedorkova has over a decade of experience working in SBIR/STTR program development and implementation across Institutes and Centers, and ran NIH's flagship CAP program.
EVENT BRIEFThis is an intense, hands‐on clinic covering strategies for leveraging NIH SBIR/STTR programs for commercial success. Dr. Lenka Fedorkova will provide an overview and unique perspective based on actual cases and lessons learned from successful NIH awardees. The afternoon will be dedicated to group coaching of companies based on one‐page briefs prepared by the participants.
MORNING VALUE PROPOSITION- NIH funding options beyond Phase I and Phase II SBIR/STTR
- Asking for and justifying maximum grant funds
- Building relationships with ICs
- Do’s and Don’ts when targeting more than one IC
- Get the most of business assistance programs: I‐ Corp, Niche Assessment Program (NAP), CommercializationAccelerator Program (CAP)
- Aligning funding and business assistance programs
- Showcase your company through NIH
- When and how to tap into CDC and FDA
- Summary statements and resubmissions
- Coaching based on one‐page brief
- Improving your write‐ups to draw reviewer attention
- Making your commercialization plan relevant to NIH
- Understanding where your technology “is” and where it needs to “go”